Houston-first directory · 6 checked local clinicians · No patient lead forms
pPEPTIDE HEALTHDIRECTORY & EVIDENCE NOTES
← FDA shortage tracker

Sodium chloride IV solution

Regulatory registry

Context
FDA-approved product context
Reason / limits
Product-specific saline information; concentrations and routes are not interchangeable.
Last source review
October 10, 2026
Review scope
Earlier editorial source context. Not a new medical or regulatory review.
Clinical phase
Unknown: no current trial-specific phase check is included in this registry.
Registry NDC / manufacturer
Unknown unless linked to a matched FDA package record below.

Research-only means this library makes no approved-treatment claim. Compounding context does not mean compounded-only, authorized for compounding, or legally available. Product-specific source limits control.

Regulatory sources

Original regulatory / editorial source

Read the full evidence note

FDA shortage tracker

Approval context and shortage status are separate. An NDC identifies a package; it does not establish FDA approval or permission to compound.

Discontinuation / mixed records

Matched records include discontinuation notices or mixed non-current states. Check each package; no compound-wide stock conclusion is made.

FDA dataset: 2026-10-16. Retrieved: Oct 16, 2026, 1:45 PM CDT.

Full dated shortage record · All compound tracker entries

Matched package records (3)

Records match a single exact active substance. Route and presentation are shown separately; a record does not apply to every product or preparation.

Sodium Chloride 0.9% Injection

Package NDC
0409-7101-66
Manufacturer
Hospira, Inc., a Pfizer Company
Product / route
SODIUM CHLORIDE / INTRAVENOUS
FDA record status
To Be Discontinued
Reported availability
Unknown
FDA reason
Not supplied
FDA record updated
12/03/2025

FDA API record for this package

Sodium Chloride 0.9% Injection

Package NDC
0409-7101-02
Manufacturer
Hospira, Inc., a Pfizer Company
Product / route
SODIUM CHLORIDE / INTRAVENOUS
FDA record status
To Be Discontinued
Reported availability
Unknown
FDA reason
Not supplied
FDA record updated
12/03/2025

FDA API record for this package

Sodium Chloride 0.9% Injection

Package NDC
0409-7101-67
Manufacturer
Hospira, Inc., a Pfizer Company
Product / route
SODIUM CHLORIDE / INTRAVENOUS
FDA record status
To Be Discontinued
Reported availability
Unknown
FDA reason
Not supplied
FDA record updated
12/03/2025

FDA API record for this package

Observed change history (1)

Observed dates are when our sync saw a source state, not when a shortage started or ended. Unchanged daily checks do not add duplicate events.